Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunologic Activity of Multiple Infusions of APN401

NCT03087591 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT03087591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunologic Activity of Multiple Infusions of APN401
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2017
Completion date
December 8, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant neoplasm in the brain, metastatic solid neoplasm, recurrent colorectal carcinoma, recurrent pancreatic carcinoma, recurrent solid neoplasm, stage iv colorectal cancer, stage iv pancreatic cancer, stage iva colorectal cancer, stage iva pancreatic cancer, stage ivb colorectal cancer, stage ivb pancreatic cancer, unresectable solid neoplasm